Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size ($ in 1000's) |
---|---|---|---|
STRUCTURE THERAPEUTICS INC | 2,109,584 | +606,837 | $85,987 |
GPCR | 2,109,584 | +606,837 | $85,987 |
INHIBRX INC | 1,750,387 | UNCH | $66,515 |
INBX | 1,750,387 | UNCH | $66,515 |
ICOSAVAX INC | 3,703,704 | UNCH | $58,370 |
ICVX | 3,703,704 | UNCH | $58,370 |
AN2 Therapeutics Inc. | 2,678,209 | UNCH | $54,877 |
ANTX | 2,678,209 | UNCH | $54,877 |
RAYZEBIO INC. | 869,908 | UNCH | $54,082 |
RYZB | 869,908 | UNCH | $54,082 |
AEROVATE THERAPEUTICS INC | 2,201,274 | UNCH | $49,815 |
AVTE | 2,201,274 | UNCH | $49,815 |
GERON CORP | 23,375,839 | UNCH | $49,323 |
GERN | 23,375,839 | UNCH | $49,323 |
SAVARA INC. | 10,000,000 | UNCH | $47,000 |
SVRA | 10,000,000 | UNCH | $47,000 |
GRACELL BIOTECHNOLOGIES INC. | 4,514,786 | +1,475,897 | $45,328 |
GRCL | 4,514,786 | +1,475,897 | $45,328 |
MADRIGAL PHARMACEUTICALS INC | 179,917 | UNCH | $41,629 |
MDGL | 179,917 | UNCH | $41,629 |
KALVISTA PHARMACEUTICALS INC | 3,395,495 | UNCH | $41,595 |
KALV | 3,395,495 | UNCH | $41,595 |
SILENCE THERAPEUTICS PLC | 2,104,875 | UNCH | $36,562 |
SLN | 2,104,875 | UNCH | $36,562 |
COMPASS PATHWAYS PLC | 3,858,000 | UNCH | $33,758 |
CMPS | 3,858,000 | UNCH | $33,758 |
COGENT BIOSCIENCES INC | 5,631,042 | UNCH | $33,111 |
COGT | 5,631,042 | UNCH | $33,111 |
TYRA BIOSCIENCES INC | 1,989,103 | UNCH | $27,549 |
TYRA | 1,989,103 | UNCH | $27,549 |
TOURMALINE BIO INC | 1,007,902 | +1,007,902 | $26,387 |
TRML | 1,007,902 | +1,007,902 | $26,387 |
TARSUS PHARMACEUTICALS INC. | 1,142,857 | UNCH | $23,143 |
TARS | 1,142,857 | UNCH | $23,143 |
DYNE THERAPEUTICS INC | 1,650,150 | UNCH | $21,947 |
DYN | 1,650,150 | UNCH | $21,947 |
KURA ONCOLOGY INC | 1,423,642 | UNCH | $20,472 |
KURA | 1,423,642 | UNCH | $20,472 |
CENTESSA PHARMACEUTICALS PLC | 2,040,816 | UNCH | $16,245 |
CNTA | 2,040,816 | UNCH | $16,245 |
VISTAGEN THERAPEUTICS INC | $13,758 | ||
COMM | 2,676,580 | +2,676,580 | $13,758 |
Abivax SA | 1,100,000 | +1,100,000 | $11,770 |
ABVX | 1,100,000 | +1,100,000 | $11,770 |
CABALETTA BIO INC | 486,795 | UNCH | $11,050 |
CABA | 486,795 | UNCH | $11,050 |
ENTRADA THERAPEUTICS INC | 584,955 | UNCH | $8,827 |
TRDA | 584,955 | UNCH | $8,827 |
NURIX THERAPEUTICS INC | 717,654 | +717,654 | $7,406 |
NRIX | 717,654 | +717,654 | $7,406 |
C4 THERAPEUTICS INC. | 1,276,574 | UNCH | $7,213 |
CCCC | 1,276,574 | UNCH | $7,213 |
TAYSHA GENE THERAPIES INC. | 2,912,861 | -8,198,250 | $5,156 |
TSHA | 2,912,861 | -8,198,250 | $5,156 |
VENTYX BIOSCIENCES INC | 815,724 | UNCH | $2,015 |
VTYX | 815,724 | UNCH | $2,015 |
KODIAK SCIENCES INC | 267,941 | +267,941 | $815 |
KOD | 267,941 | +267,941 | $815 |
IMMUNOVANT INC | $0 (exited) | ||
IMVT | 0 | -334,853 | $0 |
MERUS N.V. | 0 | -300,000 | $0 (exited) |
MRUS | 0 | -300,000 | $0 |
See Summary: TCG Crossover Management LLC Top Holdings
See Details: Top 10 Stocks Held By TCG Crossover Management LLC
Entity | Shares/Amount Change | Position Value Change |
---|---|---|
TRML | +1,007,902 | +$26,387 |
VTGN | +2,676,580 | +$13,758 |
ABVX | +1,100,000 | +$11,770 |
NRIX | +717,654 | +$7,406 |
KOD | +267,941 | +$815 |
Entity | Shares/Amount Change | Position Value Change |
---|---|---|
IMVT | -334,853 | -$12,855 |
MRUS | -300,000 | -$7,074 |
Entity | Shares/Amount Change | Position Value Change |
---|---|---|
GRCL | +1,475,897 | +$36,576 |
GPCR | +606,837 | +$10,218 |
INBX | UNCH | +$34,395 |
ICVX | UNCH | +$29,666 |
ANTX | UNCH | +$11,811 |
RYZB | UNCH | +$34,770 |
AVTE | UNCH | +$19,944 |
GERN | UNCH | -$234 |
SVRA | UNCH | +$9,200 |
MDGL | UNCH | +$15,354 |
Entity | Shares/Amount Change | Position Value Change |
---|---|---|
TSHA | -8,198,250 | -$29,955 |
VTYX | UNCH | -$26,315 |
CCCC | UNCH | +$4,839 |
TRDA | UNCH | -$415 |
CABA | UNCH | +$3,641 |
CNTA | UNCH | +$3,041 |
KURA | UNCH | +$7,488 |
DYN | UNCH | +$7,162 |
TARS | UNCH | +$2,834 |
Size ($ in 1000's)
At 12/31/2023: $901,705 At 09/30/2023: $679,114 TCG Crossover Management LLC holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from TCG Crossover Management LLC 13F filings. Link to 13F filings: SEC filings |